$PCRX

Pacira BioSciences Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$60.54 ▼-0.181%

Delayed Price

VOLUME

33,950

DAY RANGE

- 61.4

52 WEEK

45.05 - 82.16

Join Discuss about PCRX with like-minded investors

profile
@dros #droscrew
recently

+Initiations 1/3: $ADTH $CUE $GTN $HCP $IAC $NU $PCRX $PEAR $PRVA $REFI $VCSA

107 Replies 9 👍 7 🔥

profile
@zonatrading #Zona Trading
recently

$PCRX bastante interesante, lo unico es evaluar las resistencias historicas y que es una biotech, nunca ha sido rentable, es un patrón técnico.

105 Replies 10 👍 8 🔥

Key Metrics

Market Cap

2.76 B

Beta

0.77

Avg. Volume

502.01 K

Shares Outstanding

45.44 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-02

Next Dividend Date

Company Information

Pacira BioSciences, Inc.is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera° system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.

Website:

HQ: 5 Sylvan Way Ste 300 Parsippany, 07054-3813 New Jersey

Related News